Anti-AXIN2/ AXIL/ ODCRCS monoclonal antibody

Anti-AXIN2/ AXIL/ ODCRCS antibody for FACS & in-vivo assay

Target products collectionGo to AXIN2/AXIN2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2013-Ab-1/ GM-Tg-hg-MP2013-Ab-2Anti-Human AXIN2 monoclonal antibodyHuman
GM-Tg-rg-MP2013-Ab-1/ GM-Tg-rg-MP2013-Ab-2Anti-Rat AXIN2 monoclonal antibodyRat
GM-Tg-mg-MP2013-Ab-1/ GM-Tg-mg-MP2013-Ab-2Anti-Mouse AXIN2 monoclonal antibodyMouse
GM-Tg-cynog-MP2013-Ab-1/ GM-Tg-cynog-MP2013-Ab-2Anti-Cynomolgus/ Rhesus macaque AXIN2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2013-Ab-1/ GM-Tg-felg-MP2013-Ab-2Anti-Feline AXIN2 monoclonal antibodyFeline
GM-Tg-cang-MP2013-Ab-1/ GM-Tg-cang-MP2013-Ab-2Anti-Canine AXIN2 monoclonal antibodyCanine
GM-Tg-bovg-MP2013-Ab-1/ GM-Tg-bovg-MP2013-Ab-2Anti-Bovine AXIN2 monoclonal antibodyBovine
GM-Tg-equg-MP2013-Ab-1/ GM-Tg-equg-MP2013-Ab-2Anti-Equine AXIN2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2013-Ab-1/ GM-Tg-hg-MP2013-Ab-2; GM-Tg-rg-MP2013-Ab-1/ GM-Tg-rg-MP2013-Ab-2;
GM-Tg-mg-MP2013-Ab-1/ GM-Tg-mg-MP2013-Ab-2; GM-Tg-cynog-MP2013-Ab-1/ GM-Tg-cynog-MP2013-Ab-2;
GM-Tg-felg-MP2013-Ab-1/ GM-Tg-felg-MP2013-Ab-2; GM-Tg-cang-MP2013-Ab-1/ GM-Tg-cang-MP2013-Ab-2;
GM-Tg-bovg-MP2013-Ab-1/ GM-Tg-bovg-MP2013-Ab-2; GM-Tg-equg-MP2013-Ab-1/ GM-Tg-equg-MP2013-Ab-2
Products NameAnti-AXIN2 monoclonal antibody
Formatmab
Target NameAXIN2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-AXIN2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species AXIN2/ AXIL/ ODCRCS VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2013
    Target NameAXIN2
    Gene ID8313,12006,29134,718566,490903,101093061,511619,100630049
    Gene Symbol and SynonymsAxi1,AXIL,axin-2,AXIN2,Conductin,ODCRCS
    Uniprot AccessionQ9Y2T1,O70240
    Uniprot Entry NameAXIN2_HUMAN,AXIN2_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000168646
    Target ClassificationTumor-associated antigen (TAA)

    The target: AXIN2, gene name: AXIN2, also named as AXIL, ODCRCS. The Axin-related protein, Axin2, presumably plays an important role in the regulation of the stability of beta-catenin in the Wnt signaling pathway, like its rodent homologs, mouse conductin/rat axil. In mouse, conductin organizes a multiprotein complex of APC (adenomatous polyposis of the colon), beta-catenin, glycogen synthase kinase 3-beta, and conductin, which leads to the degradation of beta-catenin. Apparently, the deregulation of beta-catenin is an important event in the genesis of a number of malignancies. The AXIN2 gene has been mapped to 17q23-q24, a region that shows frequent loss of heterozygosity in breast cancer, neuroblastoma, and other tumors. Mutations in this gene have been associated with colorectal cancer with defective mismatch repair. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.